West Chester, PA, United States of America

Yuda Zong

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovator Spotlight: Yuda Zong**

Introduction

Yuda Zong is a talented inventor based in West Chester, Pennsylvania. With a focus on pharmaceutical innovations, he holds a notable patent that addresses critical advancements in drug performance and processability.

Latest Patents

Yuda Zong's sole patent, titled "Pharmaceutical compositions with enhanced performance and improved processability," showcases his innovative work with polymers. The inventive concept revolves around a unique polymer formulation comprising hydroxypropyl methyl cellulose acetate succinate (HPMC-AS). This innovation is characterized by specific properties, including a total succinoyl degree of substitution of less than 12% at the C6-OH position and greater than 53% at the C3-OH position. Additionally, this polymer exhibits a total acetyl degree of substitution that exceeds 32% at the C6-OH position, significantly contributing to improved drug formulation performance.

Career Highlights

Yuda Zong is currently employed at Hercules Corporation, a company renowned for its commitment to innovation in materials and chemical technologies. His role there has allowed him to develop and refine his patents, contributing to advancements in pharmaceutical sciences.

Collaborations

Throughout his career, Yuda has collaborated with several talented colleagues, including Todd Andrew Brugel and Tuyen T Nguyen. These partnerships have fostered a creative environment, enabling the exchange of ideas and further innovations in their field.

Conclusion

Yuda Zong stands out as a committed inventor whose work significantly enhances pharmaceutical formulations. His patent reflects a deep understanding of polymer chemistry and its application in improving drug performance, likely paving the way for future innovations in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…